India recommends nod to SII for phase 2/3 trials of Covid-19 vaccine Covovaxon children
NEW DELHI: An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India...
NEW DELHI: An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India...
NEW DELHI: India recorded less than 30,000 fresh COVID-19 cases after 132 days while its active caseload fell below 4,00,000...
NEW DELHI: Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can...